Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling

Cell Adhesion and Migration

Volumn 8, Issue 2, 2014, Pages 76-83

  Wilson, Christopher W ^a   Ye, Weilan ^a  

^a GENENTECH INC   (United States)

Author keywords

Angiogenesis; Effectors; Endothelial cells; Epac1; Junctions; Rap1; Rasip1; Vasculogenesis; VE cadherin

Indexed keywords

ACTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; RAP1 PROTEIN; RAS INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; CADHERIN; CARRIER PROTEIN; EPAC PROTEIN, MOUSE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LEUKOCYTE ANTIGEN; RASIP1 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A;

ANGIOGENESIS; CARDIOVASCULAR SYSTEM; CELL ADHESION; CELL CONTACT; CELL INTERACTION; CELL JUNCTION; CELL STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION; ACTIN FILAMENT; ANIMAL; CELL DIFFERENTIATION; ENDOTHELIUM CELL; GENETICS; METABOLISM; MOUSE;

ACTIN CYTOSKELETON; ANIMALS; ANTIGENS, CD; CADHERINS; CARRIER PROTEINS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INTERCELLULAR JUNCTIONS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RAP1 GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901435760     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.28115     Document Type: Review

References (75)

1. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473:298-307; PMID:21593862; http://dx.doi.org/10. 1038/nature10144
2. Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 2011; 27:563-84; PMID:21756109; http://dx.doi.org/10.1146/ annurev-cellbio-092910-154002
3. Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 2010; 51:2813-26; PMID:20484600; http://dx.doi.org/10.1167/iovs.10-5176
4. Konisti S, Kiriakidis S, Paleolog EM. Hypoxia - a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012; 8:153-62; PMID:22293762; http://dx.doi.org/10.1038/nrrheum.2011.205
5. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350:2335-42; PMID:15175435; http://dx.doi.org/10.1056/NEJMoa032691
6. Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007; 357:2666-76; PMID:18160686; http://dx.doi.org/10.1056/NEJMoa072113
7. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxelcarboplatin alone or with bevacizumab for non-smallcell lung cancer. N Engl J Med 2006; 355:2542-50; PMID:17167137; http://dx.doi.org/10.1056/NEJMoa061884
8. Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012; 320:130-7; PMID:22425960; http://dx.doi.org/10.1016/j.canlet.2012.03.008
9. Schlingemann RO, Witmer AN. Treatment of retinal diseases with VEGF antagonists. Prog Brain Res 2009; 175:253-67; PMID:19660661; http://dx.doi.org/10.1016/S0079-6123(09)17517-9
10. Vestweber D. Novel insights into leukocyte extravasation. Curr Opin Hematol 2012; 19:212-7; PMID:22395664; http://dx.doi.org/10.1097/MOH. 0b013e3283523e78
11. Dejana E, Giampietro C. Vascular endothelial-cadherin and vascular stability. Curr Opin Hematol 2012; 19:218-23; PMID:22395663; http://dx.doi.org/10.1097/MOH.0b013e3283523e1c
12. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 2013; 498:492-6; PMID:23748444; http://dx.doi.org/10.1038/nature12207
13. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009; 17:860-71; PMID:19337313; http://dx.doi.org/10.1038/ejhg.2009.35
14. Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009; 16:209-21; PMID:19217423; http://dx.doi.org/10. 1016/j.devcel.2009.01.004
15. Takai Y, Miyoshi J, Ikeda W, Ogita H. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 2008; 9:603-15; PMID:18648374; http://dx.doi.org/10.1038/nrm2457
16. Shapiro L, Weis WI. Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 2009; 1:a003053; PMID:20066110; http://dx.doi.org/10.1101/cshperspect.a003053
17. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 2005; 123:903-15; PMID:16325583; http://dx.doi.org/10.1016/j. cell.2005.09.021
18. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell 2005; 123:889-901; PMID:16325582; http://dx.doi.org/10.1016/j.cell.2005.09.020
19. Oas RG, Nanes BA, Esimai CC, Vincent PA, García AJ, Kowalczyk AP. p120-catenin and β-catenin differentially regulate cadherin adhesive function. Mol Biol Cell 2013; 24:704-14; PMID:23325790; http://dx.doi.org/10. 1091/mbc.E12-06-0471
20. Kourtidis A, Ngok SP, Anastasiadis PZ. p120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression. Prog Mol Biol Transl Sci 2013; 116:409-32; PMID:23481205; http://dx.doi.org/10.1016/B978-0-12-394311-8.00018-2
21. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 2001; 97:1679-84; PMID:11238107; http://dx.doi.org/10.1182/blood.V97.6.1679
22. Gotsch U, Borges E, Bosse R, Böggemeyer E, Simon M, Mossmann H, Vestweber D. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 1997; 110:583-8; PMID:9092940
23. Schulte D, Küppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, et al. Stabilizing the VE-cadherincatenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011; 30:4157-70; PMID:21857650; http://dx.doi.org/10.1038/ emboj.2011.304
24. Strilić B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 2009; 17:505-15; PMID:19853564; http://dx.doi.org/10.1016/j.devcel.2009.08.011
25. Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, Dejana E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 2010; 123:1073-80; PMID:20332120; http://dx.doi.org/10. 1242/jcs.059329
26. Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci 2013; 126:2545-9; PMID:23781019; http://dx.doi.org/10.1242/jcs.124529
27. Fernández-Martín L, Marcos-Ramiro B, Bigarella CL, Graupera M, Cain RJ, Reglero-Real N, Jiménez A, Cernuda-Morollón E, Correas I, Cox S, et al. Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 2012; 32:e90-102; PMID:22723439; http://dx.doi.org/10.1161/ATVBAHA.112.252080
28. Huveneers S, Oldenburg J, Spanjaard E, van der Krogt G, Grigoriev I, Akhmanova A, Rehmann H, de Rooij J. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. J Cell Biol 2012; 196:641-52; PMID:22391038; http://dx.doi.org/10.1083/jcb.201108120
29. Millán J, Cain RJ, Reglero-Real N, Bigarella C, Marcos-Ramiro B, Fernández-Martín L, Correas I, Ridley AJ. Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol 2010; 8:11; PMID:20122254; http://dx.doi.org/10.1186/1741-7007-8-11
30. Hoelzle MK, Svitkina T. The cytoskeletal mechanisms of cell-cell junction formation in endothelial cells. Mol Biol Cell 2012; 23:310-23; PMID:22090347; http://dx.doi.org/10.1091/mbc.E11-08-0719
31. Huveneers S, de Rooij J. Mechanosensitive systems at the cadherin-F-actin interface. J Cell Sci 2013; 126:403-13; PMID:23524998; http://dx.doi.org/10. 1242/jcs.109447
32. Yonemura S, Wada Y, Watanabe T, Nagafuchi A, Shibata M. alpha-Catenin as a tension transducer that induces adherens junction development. Nat Cell Biol 2010; 12:533-42; PMID:20453849; http://dx.doi.org/10.1038/ncb2055
33. Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol 2013; 14:503-17; PMID:23860236; http://dx.doi.org/10.1038/nrm3624
34. Frische EW, Zwartkruis FJ. Rap1, a mercenary among the Ras-like GTPases. Dev Biol 2010; 340:1-9; PMID:20060392; http://dx.doi.org/10.1016/j.ydbio.2009. 12.043
35. Cherfils J, Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 2013; 93:269-309; PMID:23303910; http://dx.doi.org/10.1152/ physrev.00003.2012
36. Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL. Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim Biophys Acta 2009; 1788:790-6; PMID:19159611; http://dx.doi.org/10.1016/ j.bbamem.2008.12.010
37. Chrzanowska-Wodnicka M. Regulation of angiogenesis by a small GTPase Rap1. Vascul Pharmacol 2010; 53:1-10; PMID:20302970; http://dx.doi.org/10.1016/ j.vph.2010.03.003
38. Yan J, Li F, Ingram DA, Quilliam LA. Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol Cell Biol 2008; 28:5803-10; PMID:18625726; http://dx.doi.org/10.1128/MCB.00393-08
39. nd, Paranavitana NC, Peng X, Kim C, Munugalavadla V, et al. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol 2007; 179:8322-31; PMID:18056377
40. Duchniewicz M, Zemojtel T, Kolanczyk M, Grossmann S, Scheele JS, Zwartkruis FJ. Rap1Adeficient T and B cells show impaired integrinmediated cell adhesion. Mol Cell Biol 2006; 26:643-53; PMID:16382154; http://dx.doi.org/10. 1128/MCB.26.2.643-653.2006
41. nd. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005; 115:680-7; PMID:15696195; http://dx.doi.org/10.1172/ JCI22973
42. nd, Vansluys J. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 2008; 111:2647-56; PMID:17993608; http://dx.doi.org/10.1182/blood-2007-08-109710
43. 3. Blood 2011; 118:2015-26; PMID:21636859; http://dx.doi.org/10.1182/blood-2011-04-349282
44. Chrzanowska-Wodnicka M. Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction. Exp Cell Res 2013; 319:2350-9; PMID:23911990; http://dx.doi.org/10.1016/j.yexcr.2013.07.022
45. Carmona G, Göttig S, Orlandi A, Scheele J, Bäuerle T, Jugold M, Kiessling F, Henschler R, Zeiher AM, Dimmeler S, et al. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood 2009; 113:488-97; PMID:18805968; http://dx.doi.org/10.1182/ blood-2008-02-138438
46. Hong J, Doebele RC, Lingen MW, Quilliam LA, Tang WJ, Rosner MR. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem 2007; 282:19781-7; PMID:17491018; http://dx.doi.org/10.1074/jbc.M700128200
47. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998; 396:474-7; PMID:9853756; http://dx.doi.org/10.1038/ 24884
48. Kooistra MR, Corada M, Dejana E, Bos JL. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 2005; 579:4966-72; PMID:16115630; http://dx.doi.org/10.1016/j.febslet.2005.07.080
49. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 2005; 25:136-46; PMID:15601837; http://dx.doi.org/10.1128/MCB.25.1.136-146.2005
50. Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, Burridge K. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem 2005; 280:11675-82; PMID:15661741; http://dx.doi.org/10. 1074/jbc.M412595200
51. Pannekoek WJ, van Dijk JJ, Chan OY, Huveneers S, Linnemann JR, Spanjaard E, Brouwer PM, van der Meer AJ, Zwartkruis FJ, Rehmann H, et al. Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell Signal 2011; 23:2056-64; PMID:21840392; http://dx.doi.org/10.1016/j.cellsig.2011.07.022
52. Birukova AA, Zagranichnaya T, Fu P, Alekseeva E, Chen W, Jacobson JR, Birukov KG. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res 2007; 313:2504-20; PMID:17493609; http://dx.doi.org/10.1016/j.yexcr.2007.03.036
53. Wilson CW, Parker LH, Hall CJ, Smyczek T, Mak J, Crow A, Posthuma G, De Mazière A, Sagolla M, Chalouni C, et al. Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling. Blood 2013; 122:3678-90; PMID:23886837; http://dx.doi.org/10.1182/blood-2013-02-483156
54. Wittchen ES, Aghajanian A, Burridge K. Isoformspecific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases 2011; 2:65-76; PMID:21776404; http://dx.doi.org/10.4161/sgtp.2.2. 15735
55. Smutny M, Cox HL, Leerberg JM, Kovacs EM, Conti MA, Ferguson C, Hamilton NA, Parton RG, Adelstein RS, Yap AS. Myosin II isoforms identify distinct functional modules that support integrity of the epithelial zonula adherens. Nat Cell Biol 2010; 12:696-702; PMID:20543839; http://dx.doi.org/10.1038/ncb2072
56. Takai Y, Ikeda W, Ogita H, Rikitake Y. The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu Rev Cell Dev Biol 2008; 24:309-42; PMID:18593353; http://dx.doi.org/10.1146/annurev.cellbio. 24.110707.175339
57. Tawa H, Rikitake Y, Takahashi M, Amano H, Miyata M, Satomi-Kobayashi S, Kinugasa M, Nagamatsu Y, Majima T, Ogita H, et al. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis. Circ Res 2010; 106:1731-42; PMID:20413783; http://dx.doi.org/10.1161/CIRCRESAHA. 110.216747
58. Ikeda W, Nakanishi H, Miyoshi J, Mandai K, Ishizaki H, Tanaka M, Togawa A, Takahashi K, Nishioka H, Yoshida H, et al. Afadin: A key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. J Cell Biol 1999; 146:1117-32; PMID:10477764; http://dx.doi.org/10.1083/jcb.146.5.1117
59. Majima T, Takeuchi K, Sano K, Hirashima M, Zankov DP, Tanaka-Okamoto M, Ishizaki H, Miyoshi J, Ogita H. An Adaptor Molecule Afadin Regulates Lymphangiogenesis by Modulating RhoA Activity in the Developing Mouse Embryo. PLoS One 2013; 8:e68134; PMID:23840823; http://dx.doi.org/10.1371/journal.pone. 0068134
60. Zhadanov AB, Provance DW Jr., Speer CA, Coffin JD, Goss D, Blixt JA, Reichert CM, Mercer JA. Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr Biol 1999; 9:880-8; PMID:10469590; http://dx.doi.org/10.1016/S0960-9822(99) 80392-3
61. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 1997; 15:1043-9; PMID:9285558; http://dx.doi.org/10.1038/sj.onc.1201268
62. Béraud-Dufour S, Gautier R, Albiges-Rizo C, Chardin P, Faurobert E. Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J 2007; 274:5518-32; PMID:17916086; http://dx.doi.org/10.1111/j.1742-4658.2007.06068.x
63. Glading A, Han J, Stockton RA, Ginsberg MH. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 2007; 179:247-54; PMID:17954608; http://dx.doi.org/10.1083/jcb.200705175
64. Stockton RA, Shenkar R, Awad IA, Ginsberg MH. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 2010; 207:881-96; PMID:20308363; http://dx.doi.org/10.1084/jem.20091258
65. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC. Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 2001; 10:2953-60; PMID:11741838; http://dx.doi.org/10.1093/hmg/10.25.2953
66. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 2004; 131:1437-48; PMID:14993192; http://dx.doi.org/10.1242/dev.01036
67. Mitin NY, Ramocki MB, Zullo AJ, Der CJ, Konieczny SF, Taparowsky EJ. Identification and characterization of rain, a novel Ras-interacting protein with a unique subcellular localization. J Biol Chem 2004; 279:22353-61; PMID:15031288; http://dx.doi.org/10.1074/jbc.M312867200
68. Xu K, Chong DC, Rankin SA, Zorn AM, Cleaver O. Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev Biol 2009; 329:269-79; PMID:19272373; http://dx.doi.org/10.1016/j.ydbio.2009.02.033
69. Xu K, Sacharidou A, Fu S, Chong DC, Skaug B, Chen ZJ, Davis GE, Cleaver O. Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev Cell 2011; 20:526-39; PMID:21396893; http://dx.doi.org/10.1016/j.devcel. 2011.02.010
70. Post A, Pannekoek WJ, Ross SH, Verlaan I, Brouwer PM, Bos JL. Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29. Proc Natl Acad Sci U S A 2013; 110:11427-32; PMID:23798437; http://dx.doi.org/10.1073/pnas.1306595110
71. Ando K, Fukuhara S, Moriya T, Obara Y, Nakahata N, Mochizuki N. Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization. J Cell Biol 2013; 202:901-16; PMID:24019534; http://dx.doi.org/10.1083/jcb.201301115
72. Smolen GA, Schott BJ, Stewart RA, Diederichs S, Muir B, Provencher HL, Look AT, Sgroi DC, Peterson RT, Haber DA. A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev 2007; 21:2131-6; PMID:17704304; http://dx.doi.org/10.1101/gad.1561507
73. Yan J, Mei FC, Cheng H, Lao DH, Hu Y, Wei J, Patrikeev I, Hao D, Stutz SJ, Dineley KT, et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol Cell Biol 2013; 33:918-26; PMID:23263987; http://dx.doi.org/10.1128/MCB.01227-12
74. Kai AK, Lam AK, Chen Y, Tai AC, Zhang X, Lai AK, Yeung PK, Tam S, Wang J, Lam KS, et al. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome. FASEB J 2013; 27:4122-35; PMID:23825225; http://dx.doi.org/10.1096/fj.13-230433
75. Sehrawat S, Cullere X, Patel S, Italiano J Jr., Mayadas TN. Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell 2008; 19:1261-70; PMID:18172027; http://dx.doi.org/10.1091/mbc.E06-10-0972